Filing Details

Accession Number:
0001140361-14-046080
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-22 11:04:17
Reporting Period:
2014-12-18
Filing Date:
2014-12-22
Accepted Time:
2014-12-22 11:04:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587774 Blasius Eric Risser 9640 Medical Center Drive
Rockville MD 20850
Vp, Business Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-18 10,000 $0.94 10,000 No 4 M Direct
Common Stock Disposition 2014-12-18 10,000 $33.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-12-18 10,000 $0.94 10,000 $0.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,836 2009-09-24 2019-03-23 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 31, 2014.
  2. The price reported in Column 4 is a weighted average price.